Eplerenone is a steroidal antimineralocorticoid of the spirolactone group that functions as a selective aldosterone receptor antagonist. It is primarily indicated for the treatment of hypertension and… Read more
![Chemical structure of (4aS,4bR,5aR,6aS,7R)-4a,6a-Dimethyl-3',4,4a,4',6,6a,8,9,9a,9b,10,11-dodecahydro-3H,5'H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,2'-furan]-2,5'(5aH)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4aS4bR5aR6aS7R-4a6a-Dimethyl-344a466a899a9b1011-dodecahydro-3H5H-spirocyclopenta12phenanthro44a-boxirene-72-furan-255aH-dione.png&w=3840&q=75)
![Chemical structure of (4aS,4bR,5aR,6aS,7R,9aS,9bR,10R)-4a,6a-Dimethyl-2,5'-dioxo-2,4,4a,4',5a,5',6,6a,8,9,9a,9b,10,11-tetradecahydro-3H,3'H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,2'-furan]-10-carbonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F910107-80-1-4aS4bR5aR6aS7R9aS9bR10R-4a6a-Dimethyl-25-dioxo-244a45a566a899a9b1011-tetradecahydro-3H3H-spirocyclopenta12phenanthro44a-boxirene-72-furan-.png&w=3840&q=75)
![Chemical structure of (4aS,4bR,5aR,6aS,7R,9aS,9bS)-4a,6a-Dimethyl-3',4,4a,4',6,6a,8,9,9a,9b,10,11-dodecahydro-3H,5'H-spiro[cyclopenta[1,2]phenanthro[4,4a-b]oxirene-7,2'-furan]-2,5'(5aH)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4aS4bR5aR6aS7R9aS9bS-4a6a-Dimethyl-344a466a899a9b1011-dodecahydro-3H5H-spirocyclopenta12phenanthro44a-boxirene-72-furan-255aH-dione.png&w=3840&q=75)
![Chemical structure of (7R,8R,10S,13S,14S,17R)-10,13-Dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7R8R10S13S14S17R-1013-Dimethyl-35-dioxo-12345678101213141516-tetradecahydro-3H-spirocyclopentaaphenanthrene-172-furan-7-carboxylic-Acid.png&w=3840&q=75)














































Eplerenone is a steroidal antimineralocorticoid of the spirolactone group that functions as a selective aldosterone receptor antagonist. It is primarily indicated for the treatment of hypertension and as an adjunct therapy in the management of congestive heart failure, particularly in patients with left ventricular systolic dysfunction following an acute myocardial infarction. The compounds in this category—including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled standards—are essential for comprehensive pharmaceutical analysis. Laboratories utilize these high-quality reference standards for rigorous impurity profiling, analytical method validation, and routine quality control testing. By facilitating the accurate identification and quantification of process-related substances and degradation products, these materials support compliance with international regulatory guidelines and help ensure the safety, efficacy, and consistency of pharmaceutical formulations throughout the drug development and manufacturing lifecycle.